Page 9 - Topline News Today

The trial confirms ALE.F02's good safety profile, exposure and target biological activity Alentis Therapeutics ("Alentis"), the clinical-stage biotechnology company developing breakthrough treatments

– Topline Data from fourth cohort of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint –– Company will focus on development of extracellular vesicles ... | April 26, 2023

The bear onslaught on 10 technology stocks comprising the Nifty IT index wiped ₹1.03 trillion off investor wealth, with Infosys Ltd alone accounting for a little more than half of the losses

MAIA Biotechnology, Inc. today announced positive topline data from the completed Part A safety lead-in of the Company’s THIO-101 Phase 2 go-to-market trial in advanced Non-Small Cell Lung... | April 11, 2023

· REVENUES UP 15% AT €90.6 MILLION [8% LIKE-FOR-LIKE] · MONTHLY RECURRING REVENUE PROGRESS BY 25%, EXCEEDING TOTAL TOPLINE GROWTH · EBITDA OF €5.0 MILLION;... | April 6, 2023

Waterford Police Officer Adam Lapkowski was found dead this week at Poquetanuck Cemetery in Preston, where his mother, who was killed in 1996, is buried.

EQS-News: MorphoSys AG / Key word: Miscellaneous MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2023... | April 4, 2023

Advanced preparations for potential commercial launch of BT-001 in U.S. in mid-2023 Reported positive topline results from exploratory trial for fatty liver disease Announced restructuring and... | March 30, 2023

* Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel in patients with Fragile X syndrome; topline results expected first-half 2024 * European Commission granted orphan... | March 29, 2023

Completed enrollment of the Phase 2 PEAK Trial of AVTX-002 in non-eosinophilic asthma ; topline data expected in the second quarter of 2023Disclosed cash of approximately $13 million as of... | March 29, 2023